Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
Holding BSEM?
Track your performance easily
BSEM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.11 - $15.50
Previous Close$9.76
Volume3.46K
Average Volume (3M)30.07K
Market Cap
$162.43M
Enterprise Value$164.15M
Total Cash (Recent Filing)$238.87K
Total Debt (Recent Filing)$5.78M
Price to Earnings (P/E)28.5
Beta0.81
Next Earnings
Nov 12, 2024EPS Estimate
$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.34
Shares Outstanding16,287,139
10 Day Avg. Volume36,045
30 Day Avg. Volume30,075
Standard Deviation0.36
R-Squared0.07
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-26.38
Price to Sales (P/S)57.84
Price to Cash Flow (P/CF)2032.90
P/FCF Ratio273.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue60.87
Enterprise Value/Gross Profit131.13
Enterprise Value/Ebitda-106.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioStem Technologies News
BSEM FAQ
What was BioStem Technologies Inc’s price range in the past 12 months?
BioStem Technologies Inc lowest stock price was $2.11 and its highest was $15.50 in the past 12 months.
What is BioStem Technologies Inc’s market cap?
Currently, no data Available
When is BioStem Technologies Inc’s upcoming earnings report date?
BioStem Technologies Inc’s upcoming earnings report date is Nov 12, 2024 which is in 53 days.
How were BioStem Technologies Inc’s earnings last quarter?
BioStem Technologies Inc released its earnings results on Aug 12, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03.
Is BioStem Technologies Inc overvalued?
According to Wall Street analysts BioStem Technologies Inc’s price is currently Overvalued.
Does BioStem Technologies Inc pay dividends?
BioStem Technologies Inc does not currently pay dividends.
What is BioStem Technologies Inc’s EPS estimate?
BioStem Technologies Inc’s EPS estimate is $0.36.
How many shares outstanding does BioStem Technologies Inc have?
BioStem Technologies Inc has 16,226,720 shares outstanding.
What happened to BioStem Technologies Inc’s price movement after its last earnings report?
BioStem Technologies Inc reported an EPS of $0.3 in its last earnings report, beating expectations of $0.27. Following the earnings report the stock price went up 8.4%.
Which hedge fund is a major shareholder of BioStem Technologies Inc?
Currently, no hedge funds are holding shares in BSEM
---
BioStem Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BSEM Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.9%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
278.29%
12-Months-Change
Fundamentals
Return on Equity
178.45%
Trailing 12-Months
Asset Growth
2636.58%
Trailing 12-Months
Company Description
BioStem Technologies Inc
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on July 7, 2006 and is headquartered in Oakland Park, FL.
---
BSEM Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---